Cook Karon F, Jensen Sally E, Schalet Benjamin D, Beaumont Jennifer L, Amtmann Dagmar, Czajkowski Susan, Dewalt Darren A, Fries James F, Pilkonis Paul A, Reeve Bryce B, Stone Arthur A, Weinfurt Kevin P, Cella David
Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 633 N. St. Clair, 19th Floor, Chicago, IL 60611, USA.
Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 633 N. St. Clair, 19th Floor, Chicago, IL 60611, USA; Department of Surgery (Division of Organ Transplant), Northwestern University Feinberg School of Medicine, 251 E. Huron, Galter 3-150, Chicago, IL, USA.
J Clin Epidemiol. 2016 May;73:89-102. doi: 10.1016/j.jclinepi.2015.08.038. Epub 2016 Mar 4.
To present an overview of a series of studies in which the clinical validity of the National Institutes of Health's Patient Reported Outcome Measurement Information System (NIH; PROMIS) measures was evaluated, by domain, across six clinical populations.
Approximately 1,500 individuals at baseline and 1,300 at follow-up completed PROMIS measures. The analyses reported in this issue were conducted post hoc, pooling data across six previous studies, and accommodating the different designs of the six, within-condition, parent studies. Changes in T-scores, standardized response means, and effect sizes were calculated in each study. When a parent study design allowed, known groups validity was calculated using a linear mixed model.
The results provide substantial support for the clinical validity of nine PROMIS measures in a range of chronic conditions.
The cross-condition focus of the analyses provided a unique and multifaceted perspective on how PROMIS measures function in "real-world" clinical settings and provides external anchors that can support comparative effectiveness research. The current body of clinical validity evidence for the nine PROMIS measures indicates the success of NIH PROMIS in developing measures that are effective across a range of chronic conditions.
概述一系列研究,其中按领域对美国国立卫生研究院患者报告结局测量信息系统(NIH;PROMIS)测量指标在六个临床人群中的临床有效性进行了评估。
约1500名个体在基线时以及1300名个体在随访时完成了PROMIS测量。本期报告的分析是事后进行的,汇总了之前六项研究的数据,并考虑了六项条件内母体研究的不同设计。计算了每项研究中T分数、标准化反应均值和效应量的变化。当母体研究设计允许时,使用线性混合模型计算已知组效度。
结果为九项PROMIS测量指标在一系列慢性病中的临床有效性提供了大量支持。
分析的跨疾病重点为PROMIS测量指标在“现实世界”临床环境中的功能提供了独特且多方面的视角,并提供了可支持比较效果研究的外部锚定。目前这九项PROMIS测量指标的临床有效性证据表明,NIH PROMIS在开发适用于一系列慢性病的有效测量指标方面取得了成功。